Valuation: Byotrol plc

Market Cap 194K 261K 228K 210K 365K 25.1M 373K 2.51M 988K 12.29M 979K 957K 42.32M P/E 2023
-2.12x
P/E 2024 -0.06x
Enterprise Value 845K 1.14M 993K 916K 1.59M 109M 1.63M 10.95M 4.31M 53.6M 4.27M 4.17M 185M EV / Sales 2023
0.84x
EV / Sales 2024 0.21x
Free-Float
24.18%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 50 30/06/2024
Director TitleAgeSince
Chairman 75 21/04/2024
Director/Board Member 50 12/12/2021
Change 5-day change 1-year change 3-year change Capi.($)
-20.00%-20.00% - - 247K
-1.24%+1.78%-3.84%+0.44% 353B
+0.92%+1.61%-6.28%+3.34% 134B
-1.29%+0.57%+6.34%+22.74% 75.27B
+2.16%-0.03%-14.85%-19.91% 51.17B
-0.66%-3.00%-13.52%-24.09% 36.52B
-0.50%-0.45%-4.94%-57.29% 29.97B
-0.70%+2.03%-26.21%-31.67% 19.99B
+4.09%+1.76%+14.26%-0.04% 19.11B
+0.70%+0.85%-0.75%+24.60% 18.29B
Average -1.70%+0.97%-5.53%-9.10% 81.95B
Weighted average by Cap. -0.41%+2.10%-4.59%-2.01%

Financials

2023 2024
Net sales 4.59M 6.18M 5.4M 4.98M 8.66M 595M 8.85M 59.55M 23.42M 291M 23.2M 22.69M 1B 3.97M 5.34M 4.67M 4.31M 7.48M 514M 7.65M 51.48M 20.25M 252M 20.06M 19.62M 867M
Net income -1.69M -2.28M -1.99M -1.84M -3.19M -219M -3.26M -21.94M -8.63M -107M -8.55M -8.36M -370M -3.06M -4.12M -3.6M -3.32M -5.78M -397M -5.9M -39.73M -15.63M -194M -15.48M -15.14M -669M
Net Debt 287K 386K 337K 311K 541K 37.18M 553K 3.72M 1.46M 18.21M 1.45M 1.42M 62.69M 651K 876K 765K 706K 1.23M 84.34M 1.25M 8.44M 3.32M 41.31M 3.29M 3.22M 142M
Logo Byotrol plc
Byotrol Plc is a United Kingdom-based specialist infection prevention and control company. The Company operates globally in the animal and human healthcare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, molds, mycobacteria and algae. Its products can be used stand-alone or as ingredients within existing products, especially in personal hygiene, domestic and industrial disinfection, odor control, food production and food management. The Company sells products based on its anti-microbial technology to professional and consumer end users and retailers (product sales). In the professional sector, it serves human health, animal health and facilities management. In the consumer sector, it serves household, skin care and pet care. It serves customers in the United Kingdom; Europe, Middle East, and Africa (EMEA) and North America and Asia.
Employees
35